Is multiple sclerosis a risk factor for atherosclerosis?

Burcu Yuksel1, Pinar Koc2, Eylem Ozaydin Goksu1

  • 1Antalya Training and Research Hospital, Neurology Department, Muratpasa, 07050 Antalya, Turkey.

Abstract

Insights

Carotid intima-media thickness (CIMT) is increased in multiple sclerosis (MS) patients, suggesting it may indicate atherosclerosis predisposition better than high-sensitivity C-reactive protein (Hs-CRP). Age also impacts CIMT in MS.

Area of Science:

  • Neurology
  • Cardiovascular Science
  • Immunology

Background:

  • Multiple sclerosis (MS) is a central nervous system inflammatory demyelinating disease.
  • Atherosclerosis is a potential complication in MS patients.
  • Carotid intima-media thickness (CIMT) and high-sensitivity C-reactive protein (Hs-CRP) are markers for atherosclerosis.

Purpose of the Study:

  • To investigate carotid intima-media thickness (CIMT) and high-sensitivity C-reactive protein (Hs-CRP) levels in relapsing-remitting multiple sclerosis (RRMS) patients.
  • To identify potential predisposing factors for atherosclerosis in MS.
  • To compare the utility of CIMT and Hs-CRP as atherosclerosis markers in MS.

Main Methods:

  • A cohort of 35 RRMS patients and 34 healthy controls were assessed.
  • Measurements included CIMT, Hs-CRP, vitamin D, vitamin B12, BMI, smoking history, and EDSS scores.
  • Exclusion criteria included history of hypertension, diabetes mellitus, peripheral artery disease, and acute relapses.

Main Results:

  • Sixty-nine participants were included (mean age 35.8 years).
  • Right CIMT was significantly greater in MS patients (P<0.001), correlating with age (r=0.41, P=0.01).
  • No significant difference in CIMT was found based on Hs-CRP levels (P>0.15). Mean vitamin D levels were higher in MS patients (P<0.001).

Conclusions:

  • CIMT appears to be influenced by MS disease activity and age.
  • CIMT may be a more sensitive indicator of subclinical atherosclerosis in MS than Hs-CRP.
  • Further large-scale studies in MS populations are warranted.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
723
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
413
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
829
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
286
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
325
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K